drugset / Trial / NCT07727785

A Study in Healthy People to Compare Two Tablet Formulations of Pramipexole

NCT07727785 ↗

Phase 1 Completed 25 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The goal of this study is to find out whether pramipexole tablets made at two different production sites are handled in the same way by the body.

Timeline

Start
2026-08-05
Primary completion
2026-09-10
Completion
2026-09-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Pramipexole Unknown — Oral

Indications

No indication recorded.